Brevinin vs Cathelicidin (LL-37) — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Brevinin peptides are a family of antimicrobial peptides isolated from the skin secretions of Rana esculenta (European edible frog) and related Rana species. They are characterized by a C-terminal disulfide-bridged cyclic heptapeptide (Rana box) that confers structural stability ...
Calculate Brevinin dose →LL-37 is the sole human cathelicidin antimicrobial peptide, derived by proteolytic cleavage of the 18 kDa precursor hCAP18 (encoded by the CAMP gene). It is produced by neutrophils, epithelial cells of the skin, gut, and airways, and mast cells....
Calculate Cathelicidin (LL-37) dose →| Parameter | Brevinin | Cathelicidin (LL-37) |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | Clinical Research |
| Half-Life | Minutes (proteolytic) | < 10 min (plasma) |
| Typical Dose | N/A | Research: 1-100 ug/mL (topical) |
| Frequency | N/A | Varies by application |
| Route | Research only | Endogenous; topical/inhalation (research) |
| FDA Status | Not approved | No approval (clinical trials ongoing) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.